Table 1. . Characteristics of subjects enrolled in the prostatectomy study.
| Subect ID | Age (years) | Race | Baseline | Exit | Baseline | Exit | Randomized | Pathology |
|---|---|---|---|---|---|---|---|---|
| AA = 1; EA = 0 | 25(OH)D level | 25(OH)D level | Gleason score | Gleason score | D3 = 1 | Staging | ||
| 01 | 64 | 1 | 16.6 | 69.7 | 3 + 4 | 3 + 4 | 1 | pT2apN0 |
| 02 | 61 | 0 | 11.7 | 36.7 | 3 + 4 | 4 + 3 | 1 | pT2cpNX |
| 03 | 68 | 0 | 35.4 | 43.2 | 3 + 3 | 3 + 4 | 1 | pT2bpNX |
| 04 | 61 | 0 | 26.6 | 20.9 | 3 + 4 | 3 + 4 | 0 | pT2cpN0 |
| 05 | 66 | 0 | 21.3 | 19.3 | 3 + 3 | 3 + 4 | 0 | pT2cpN0 |
| 06 | 65 | 0 | 31.0 | 27.1 | 3 + 4 | 3 + 4 | 0 | pT3apN0 |
| 07 | 61 | 0 | 24.7 | 25.9 | 3 + 4 | 4 + 3 | 0 | pT3 pN0 |
| 08 | 62 | 0 | 36.4 | 55.0 | 4 + 4 | 3 + 4 | 1 | pT2cpN0 |
| 09 | 57 | 0 | 27.1 | 23.7 | 3 + 4 | 4 + 3 | 0 | pT2cpN0 |
| 10 | 60 | 0 | 46.9 | 58.2 | 4 + 3 | 3 + 4 | 1 | pT2cpN0 |
| 11 | 63 | 0 | 51.1 | 41.8 | 3 + 3 | 3 + 4 | 0 | pT2cpNX |
| 12 | 69 | 0 | 32.1 | 37.2 | 3 + 4 | 3 + 4 | 1 | pT2cpN0 |
| 13 | 58 | 0 | 39.7 | 36.8 | 3 + 3 | 3 + 3 | 0 | pT2cpNX |
| 14 | 50 | 0 | 56.9 | 41.3 | 3 + 4 | 3 + 3 | 0 | pT2cpN0 |
| 15 | 56 | 0 | 36.7 | 70.8 | 3 + 4 | 3 + 3 | 1 | pT2apN0 |
| 16 | 58 | 0 | 23.4 | 50.1 | 4 + 3 | 3 + 4 | 1 | pT2cpN0 |
| 17 | 67 | 1 | 32.7 | 34.1 | Intraductal | 4 + 3 | 0 | pT3bpN0 |
| 18 | 71 | 1 | 22.4 | 40.2 | 3 + 4 | 3 + 4 | 1 | pT2cpN0 |
| 19 | 70 | 1 | 30.3 | 39.5 | 3 + 4 | 3 + 4 | 1 | pT2cpN0 |
| 20 | 65 | 1 | 24.9 | 62.0 | 3 + 4 | 3 + 4 | 1 | pT3bpNX |
| 21 | 54 | 1 | 15.6 | 21.6 | 3 + 4 | 3 + 4 | 0 | pT2cpN0 |
| 22 | 61 | 1 | 14.1 | 32.8 | 3 + 4 | 3 + 4 | 1 | pT2c |
| 23 | 58 | 1 | 19.5 | 18.4 | 4 + 3 | 3 + 4 | 0 | pT2cpN0 |
| 24 | 63 | 0 | 19.9 | 35 | 3 + 3 | 3 + 3 | 1 | pT2cpN0 |
| 25 | 66 | 0 | 26.1 | 36.3 | 3 + 4 | 3 + 4 | 1 | pT2cpN0 |
| 26 | 62 | 1 | 33.7 | 29.4 | 3 + 3 | 3 + 3 | 0 | pT2cpNX |
| 27 | 62 | 1 | 28.8 | 20.9 | 3 + 4 | 3 + 3 | 0 | pT3apN0 |
Twenty-seven subjects completed the study. Age, race and randomization assignment for each enrolled subject are shown. Baseline and exit values of serum levels of 25(OH)D3 are shown in ng/ml. Baseline Gleason grade refers to the pathology assessment of the prostate biopsy preceding the surgery. Exit Gleason grade refers to the pathology assessment on the entire prostate after surgery, which may result in upgrade, downgrade or no change of the pathology assessment.